|
PATL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.225800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.638500E-03 |
| Normal-vs-Stage2 |
1.783310E-03 |
| Normal-vs-Stage3 |
7.847300E-04 |
| Normal-vs-Stage4 |
4.378400E-03 |
| Stage1-vs-Stage2 |
3.267400E-01 |
| Stage1-vs-Stage3 |
3.214600E-01 |
| Stage1-vs-Stage4 |
7.947000E-01 |
| Stage2-vs-Stage3 |
8.307600E-01 |
| Stage2-vs-Stage4 |
5.471200E-01 |
| Stage3-vs-Stage4 |
6.462600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.656920E-03 |
| Normal-vs-AfricanAmerican |
7.190300E-02 |
| Normal-vs-Asian |
3.428400E-02 |
| Caucasian-vs-AfricanAmerican |
7.691200E-01 |
| Caucasian-vs-Asian |
6.319400E-01 |
| AfricanAmerican-vs-Asian |
9.568600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.22560000000028E-05 |
| Normal-vs-Female |
2.395100E-03 |
| Male-vs-Female |
9.225700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.944600E-03 |
| Normal-vs-Age(41-60Yrs) |
5.612000E-04 |
| Normal-vs-Age(61-80Yrs) |
6.25679999999296E-05 |
| Normal-vs-Age(81-100Yrs) |
1.482480E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.140200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.195800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.006500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.188800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.491400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.768600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.573200E-01 |
| Classical-VS-Follicular |
1.409170E-04 |
| Classical-VS-Other |
1.358370E-01 |
| Classical-VS-Normal |
1.395880E-02 |
| Tall-VS-Follicular |
5.904400E-03 |
| Tall-VS-Other |
9.240200E-02 |
| Tall-VS-Normal |
2.215800E-01 |
| Follicular-VS-Other |
8.289800E-01 |
| Follicular-VS-Normal |
9.4315999998873E-07 |
| Other-VS-Normal |
9.700000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.48720000000091E-05 |
| Normal-vs-N1 |
4.075700E-03 |
| N0-vs-N1 |
7.542200E-01 |
|
|
